Published 01/04/2021 12:42 | Updated 01/04/2021 12:45
Washington – About 15 million doses of Johnson & Johnson’s coronavirus vaccine were mistakenly damaged at a factory in the United States, the report said. New York Times this Wednesday (31).
Questioned by AFP, the pharmaceutical company said it identified a batch of doses at an Emergent BioSolutions plant in Baltimore “that did not meet quality standards”, but did not confirm the specific number of vaccines affected.
The company also said the batch “never advanced to the final stages of the manufacturing process”.
“Quality and safety remain our main priorities,” he said.
O Times reported that problems with quality control may affect the future placement of this single dose vaccine and that an investigation by the US Food and Drug Administration (FDA) is expected.
Johnson & Johnson said it is sending more experts to the site to “supervise, direct and support the entire production of the anti-viral vaccine”, from which it expects to deliver an additional 24 million doses “during the month of April”.
The Emergent BioSolutions factory has not been licensed by regulators to produce a “drug substance” for the J&J vaccine, the company said, but the US media has said it is expected to produce millions of doses in the near future.
The J&J vaccine has been praised for being a single dose and not requiring temperatures as low for its conservation as those of Moderna and Pfizer, which simplifies its distribution.
Get the latest news delivered to your inbox
Follow us on social media networks